vs

Side-by-side financial comparison of Brookfield Asset Management Ltd. (BAM) and Enovis CORP (ENOV). Click either name above to swap in a different company.

Brookfield Asset Management Ltd. is the larger business by last-quarter revenue ($1.1B vs $548.9M, roughly 2.0× Enovis CORP). Brookfield Asset Management Ltd. runs the higher net margin — 56.7% vs -104.1%, a 160.7% gap on every dollar of revenue.

Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

BAM vs ENOV — Head-to-Head

Bigger by revenue
BAM
BAM
2.0× larger
BAM
$1.1B
$548.9M
ENOV
Higher net margin
BAM
BAM
160.7% more per $
BAM
56.7%
-104.1%
ENOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BAM
BAM
ENOV
ENOV
Revenue
$1.1B
$548.9M
Net Profit
$615.0M
$-571.1M
Gross Margin
59.9%
Operating Margin
84.2%
-101.7%
Net Margin
56.7%
-104.1%
Revenue YoY
-2.2%
Net Profit YoY
18.8%
EPS (diluted)
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAM
BAM
ENOV
ENOV
Q4 25
$1.1B
$548.9M
Q3 25
$974.0M
$564.5M
Q2 25
$931.0M
$558.8M
Q1 25
$954.0M
Q4 24
$561.0M
Q3 24
$873.0M
$505.2M
Q2 24
$821.0M
$525.2M
Q1 24
$786.0M
$516.3M
Net Profit
BAM
BAM
ENOV
ENOV
Q4 25
$615.0M
$-571.1M
Q3 25
$692.0M
$-36.7M
Q2 25
$584.0M
$-56.0M
Q1 25
$507.0M
Q4 24
$-703.2M
Q3 24
$537.0M
$-31.5M
Q2 24
$124.0M
$-18.6M
Q1 24
$373.0M
$-72.0M
Gross Margin
BAM
BAM
ENOV
ENOV
Q4 25
59.9%
Q3 25
59.3%
Q2 25
59.5%
Q1 25
Q4 24
54.8%
Q3 24
56.7%
Q2 24
55.0%
Q1 24
57.7%
Operating Margin
BAM
BAM
ENOV
ENOV
Q4 25
84.2%
-101.7%
Q3 25
79.1%
-3.0%
Q2 25
70.8%
-8.4%
Q1 25
61.0%
Q4 24
-118.5%
Q3 24
72.5%
-6.3%
Q2 24
80.4%
-8.4%
Q1 24
56.5%
-6.8%
Net Margin
BAM
BAM
ENOV
ENOV
Q4 25
56.7%
-104.1%
Q3 25
71.0%
-6.5%
Q2 25
62.7%
-10.0%
Q1 25
53.1%
Q4 24
-125.4%
Q3 24
61.5%
-6.2%
Q2 24
15.1%
-3.5%
Q1 24
47.5%
-13.9%
EPS (diluted)
BAM
BAM
ENOV
ENOV
Q4 25
$-9.99
Q3 25
$-0.64
Q2 25
$-0.98
Q1 25
Q4 24
$-12.69
Q3 24
$-0.58
Q2 24
$-0.34
Q1 24
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAM
BAM
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$1.6B
$33.6M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$8.9B
$2.0B
Total Assets
$17.0B
$4.4B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAM
BAM
ENOV
ENOV
Q4 25
$1.6B
$33.6M
Q3 25
$1.1B
$44.1M
Q2 25
$480.0M
$38.5M
Q1 25
$332.0M
Q4 24
$48.2M
Q3 24
$35.4M
Q2 24
$10.0M
$35.0M
Q1 24
$66.3M
Total Debt
BAM
BAM
ENOV
ENOV
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Stockholders' Equity
BAM
BAM
ENOV
ENOV
Q4 25
$8.9B
$2.0B
Q3 25
$8.5B
$2.6B
Q2 25
$8.5B
$2.6B
Q1 25
$8.5B
Q4 24
$2.6B
Q3 24
$9.0B
$3.3B
Q2 24
$3.2B
$3.3B
Q1 24
$2.2B
$3.3B
Total Assets
BAM
BAM
ENOV
ENOV
Q4 25
$17.0B
$4.4B
Q3 25
$16.5B
$5.0B
Q2 25
$16.1B
$4.9B
Q1 25
$15.0B
Q4 24
$4.7B
Q3 24
$5.6B
Q2 24
$4.2B
$5.4B
Q1 24
$5.5B
Debt / Equity
BAM
BAM
ENOV
ENOV
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAM
BAM
ENOV
ENOV
Operating Cash FlowLast quarter
$562.0M
$82.6M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
0.91×
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAM
BAM
ENOV
ENOV
Q4 25
$562.0M
$82.6M
Q3 25
$745.0M
$47.8M
Q2 25
$529.0M
$-1.6M
Q1 25
$265.0M
Q4 24
$88.3M
Q3 24
$567.0M
$53.6M
Q2 24
$159.0M
$7.8M
Q1 24
$516.0M
$-36.2M
Free Cash Flow
BAM
BAM
ENOV
ENOV
Q4 25
$29.1M
Q3 25
$3.4M
Q2 25
$-44.9M
Q1 25
Q4 24
$35.1M
Q3 24
$2.4M
Q2 24
$-31.6M
Q1 24
$-73.1M
FCF Margin
BAM
BAM
ENOV
ENOV
Q4 25
5.3%
Q3 25
0.6%
Q2 25
-8.0%
Q1 25
Q4 24
6.3%
Q3 24
0.5%
Q2 24
-6.0%
Q1 24
-14.2%
Capex Intensity
BAM
BAM
ENOV
ENOV
Q4 25
9.7%
Q3 25
7.9%
Q2 25
7.7%
Q1 25
Q4 24
9.5%
Q3 24
10.1%
Q2 24
7.5%
Q1 24
7.2%
Cash Conversion
BAM
BAM
ENOV
ENOV
Q4 25
0.91×
Q3 25
1.08×
Q2 25
0.91×
Q1 25
0.52×
Q4 24
Q3 24
1.06×
Q2 24
1.28×
Q1 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAM
BAM

Incentive Fees$452.0M42%
Infrastruture$332.0M31%
Private Equity$174.0M16%
Renewable Power And Transition$66.0M6%
Other$47.0M4%
Management And Advisory Fees$14.0M1%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons